Dopamine transporter binding in social anxiety disorder: the effect of treatment with escitalopram

James Warwick; Paul D. Carey; N Cassimjee; Christine Löchner; Sian Hemmings; Hanlie Moolman-Smook; E. Beetge; Patrick Dupont; Dan Joseph Stein

doi:10.1007/s11011-012-9280-3

Related publications

Article2010

Changes in regional brain volumes in social anxiety disorder following 12 weeks of treatment with escitalopram

N Cassimjee, Jean-Pierre Fouche, Michael F. Burnett, Christine Löchner, James Warwick, Patrick Dupont, Dan Joseph Stein, Karen J. Cloete, Paul D. Carey

Article2016

Resting functional connectivity in social anxiety disorder and the effect of pharmacotherapy

Alex Doruyter, Christine Löchner, Gerhard P. Jordaan, Dan Joseph Stein, Patrick Dupont, James Warwick

Chapter in a book2010

Social Anxiety Disorder

Michael M. Morgan, MacDonald J. Christie, Luı́s de Lecea, Jason C. G. Halford, Josée E. Leysen, Warren H. Meck, Catalin V. Buhusi, Marcy J. Bubar, Kathryn A. Cunningham, Marcy J. Bubar, Kathryn A. Cunningham, Richard W. Foltin, David C. S. Roberts, Andreas Marneros, Andreas Marneros, Alex Hofer, Bart Ellenbroek, Christoph U. Correll, Paul Newhouse, Heather Wilkins, Bart Ellenbroek, Joris C. Verster, Emma Childs, Gary Remington, Edoardo Spina, W. Wolfgang Fleischhacker,

Chapter in a book2017

Social Anxiety Disorder

Dan Joseph Stein, Norito Kawakami, Giovanni de Girolamo, Jean‐Pierre Lépine

Article2017

Resting regional brain metabolism in social anxiety disorder and the effect of moclobemide therapy

Alex Doruyter, Patrick Dupont, Lian Taljaard, Dan Joseph Stein, Christine Löchner, James Warwick

Dopamine transporter binding in social anxiety disorder: the effect of treatment with escitalopram

Discussion(0)

Related publications

Changes in regional brain volumes in social anxiety disorder following 12 weeks of treatment with escitalopram

Resting functional connectivity in social anxiety disorder and the effect of pharmacotherapy

Social Anxiety Disorder

Social Anxiety Disorder

Resting regional brain metabolism in social anxiety disorder and the effect of moclobemide therapy